Plasminogen activator inhibitor in plasma is related to testosterone in men
- 1 October 1989
- journal article
- research article
- Published by Elsevier in Metabolism
- Vol. 38 (10) , 1010-1015
- https://doi.org/10.1016/0026-0495(89)90014-0
Abstract
No abstract availableThis publication has 33 references indexed in Scilit:
- PLASMINOGEN ACTIVATOR INHIBITOR IN PLASMA: RISK FACTOR FOR RECURRENT MYOCARDIAL INFARCTIONThe Lancet, 1987
- Plasma fibrinolytic activity in a group of hypogonadic menScandinavian Journal of Clinical and Laboratory Investigation, 1987
- HAEMOSTATIC FUNCTION AND ISCHAEMIC HEART DISEASE: PRINCIPAL RESULTS OF THE NORTHWICK PARK HEART STUDYThe Lancet, 1986
- Increased Plasma Levels of a Rapid Inhibitor of Tissue Plasminogen Activator in Young Survivors of Myocardial InfarctionNew England Journal of Medicine, 1985
- Association of hyperestrogenemia and coronary heart disease in men in the Framingham cohortThe American Journal of Medicine, 1983
- Abnormal hormone levels in men with coronary artery disease.Arteriosclerosis: An Official Journal of the American Heart Association, Inc., 1982
- Δ4‐Ethylestrenol in Recurrent Deep Venous ThrombosisActa Medica Scandinavica, 1981
- RAISED PLASMA ŒSTRADIOL AND ŒSTRONE LEVELS IN YOUNG SURVIVORS OF MYOCARDIAL INFARCTIONThe Lancet, 1978
- EVIDENCE FOR HYPERŒSTROGENÆMIA AS A RISK FACTOR FOR MYOCARDIAL INFARCTION IN MENThe Lancet, 1976
- INCREASE OF BLOOD FIBRINOLYTIC ACTIVITY BY TESTOSTERONEThe Lancet, 1962